glp-1 agonists and retained gastric contents at endoscopy Glucagon-like peptide-1 receptor agonist use the risk of residual and aspiration in patients undergoing GI endoscopy: a systematic review and a meta-analysis GLP-1 RA use before endoscopy

Do not reuse

A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.

Across studies, fat mass decline predominated, whereas reductions in lean body mass were modest

GLP-1 receptor agonist 11 | C31H31ClFN3O4 | CID 168432133 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.

GLP1 is a naturally occurring ...

In November 2025, the Trump administration announced landmark agreements with Eli Lilly and Novo Nordisk reducing the monthly price of GLP-1 weight-loss drugs from over $1,000 to as low as $245 for eligible patients